Trials / Active Not Recruiting
Active Not RecruitingNCT05364229
MR-guided Tumour Boost
MR-guided Tumour Boost With Stereotactic Body Radiotherapy in Prostate Cancer
- Status
- Active Not Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- University Health Network, Toronto · Academic / Other
- Sex
- Male
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a single-arm feasibility study that is recruiting 40 patients with histologically-proven localized prostate cancer and MRI-defined lesion(s). Participants in this study will get MR-guided radiotherapy boost to MRI visible tumour before or after whole gland radiation. Participants will be followed-up as per standard of care schedule up to 5 years post-treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | MR-guided Radiotherapy Boost | IMRT/VMAT prostate whole gland SBRT to 30 Gy in 5 fractions. MRL focal boost of 15 Gy in 1 fraction will be delivered either before or after whole gland SBRT. |
Timeline
- Start date
- 2023-02-06
- Primary completion
- 2030-06-01
- Completion
- 2030-06-01
- First posted
- 2022-05-06
- Last updated
- 2026-03-05
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT05364229. Inclusion in this directory is not an endorsement.